ROBIN LEVY — Lobbyist Profile | Poliscope

ROBIN LEVY

Filings

Clients

Firms

Years active

2014–2016

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
LYMPHOMA RESEARCH FOUNDATION	9	2014–2016

Firm	Filings	Years
LYMPHOMA RESEARCH FOUNDATION	9	2014–2016

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

Cancer Drug Coverage Parity Act of 2015

Cited source text

Cancer Drug Parity Act of 2015 (H.R. 2739/ S. 1566) Department of Defense Peer Reviewed Cancer Research Program

Cancer Drug Coverage Parity Act of 2015

Cited source text

Cancer Drug Parity Act of 2015 (H.R. 2739/ S. 1566) Department of Defense Peer Reviewed Cancer Research Program

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

2016 · second_quarter · 2A

Firm income: —Client expense: $6,629Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Cancer Drug Parity Act of 2015 (H.R. 2739/ S. 1566) Department of Defense Peer Reviewed Cancer Research Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

2016 · second_quarter · Q2

Firm income: —Client expense: $6,629